<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.8" -->
<?xml-stylesheet href="http://tukraina.cytr.us/lib/exe/css.php?s=feed" type="text/css"?>
<rdf:RDF
    xmlns="http://purl.org/rss/1.0/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel rdf:about="http://tukraina.cytr.us/feed.php">
        <title>tUkraina 💙💛 glp1-t_peptide</title>
        <description></description>
        <link>http://tukraina.cytr.us/</link>
        <image rdf:resource="http://tukraina.cytr.us/lib/tpl/bootstrap3/images/favicon.ico" />
       <dc:date>2026-05-22T21:05:31+00:00</dc:date>
        <items>
            <rdf:Seq>
                <rdf:li rdf:resource="http://tukraina.cytr.us/doku.php?id=glp1-t_peptide:a_comprehensive_overview_of_its_mechanisms_benefits&amp;rev=1776081616&amp;do=diff"/>
                <rdf:li rdf:resource="http://tukraina.cytr.us/doku.php?id=glp1-t_peptide:a_novel_therapeutic_approach_in_metabolic_disorders&amp;rev=1775939841&amp;do=diff"/>
            </rdf:Seq>
        </items>
    </channel>
    <image rdf:about="http://tukraina.cytr.us/lib/tpl/bootstrap3/images/favicon.ico">
        <title>tUkraina 💙💛</title>
        <link>http://tukraina.cytr.us/</link>
        <url>http://tukraina.cytr.us/lib/tpl/bootstrap3/images/favicon.ico</url>
    </image>
    <item rdf:about="http://tukraina.cytr.us/doku.php?id=glp1-t_peptide:a_comprehensive_overview_of_its_mechanisms_benefits&amp;rev=1776081616&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-04-13T12:00:16+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>glp1-t_peptide:a_comprehensive_overview_of_its_mechanisms_benefits</title>
        <link>http://tukraina.cytr.us/doku.php?id=glp1-t_peptide:a_comprehensive_overview_of_its_mechanisms_benefits&amp;rev=1776081616&amp;do=diff</link>
        <description>Introduction

Glucagon-like peptide-1 (GLP-1) is an incretin hormone that plays a significant role in glucose metabolism and appetite regulation. The discovery of GLP-1 and its analogs has opened new avenues for the treatment of type 2 diabetes and obesity. Among these analogs, GLP1-T peptide has emerged as a promising candidate due to its unique properties and potential therapeutic applications. This report aims to provide a comprehensive overview of GLP1-T peptide, including its mechanisms of …</description>
    </item>
    <item rdf:about="http://tukraina.cytr.us/doku.php?id=glp1-t_peptide:a_novel_therapeutic_approach_in_metabolic_disorders&amp;rev=1775939841&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-04-11T20:37:21+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>glp1-t_peptide:a_novel_therapeutic_approach_in_metabolic_disorders</title>
        <link>http://tukraina.cytr.us/doku.php?id=glp1-t_peptide:a_novel_therapeutic_approach_in_metabolic_disorders&amp;rev=1775939841&amp;do=diff</link>
        <description>Abstract

Glucagon-like peptide-1 (GLP-1) is an incretin hormone that plays a crucial role in glucose metabolism and appetite regulation. The GLP1-T peptide, a modified form of GLP-1, has emerged as a promising therapeutic candidate for the treatment of type 2 diabetes and obesity. This article reviews the structure, function, and therapeutic potential of GLP1-T, highlighting its mechanisms of action, clinical applications, and future directions in research.</description>
    </item>
</rdf:RDF>
